Patent details

Basic Information

Publication number:

EP2105436

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP090753138

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Lactam-containing compounds and derivatives thereof as factor XA inhibitors

French Title of Invention:

Composés comprenant un lactame et leurs dérivés en tant qu'inhibiteurs du facteur Xa

German Title of Invention:

Lactamhaltige Verbindungen und ihre Derivate als Faktor-Xa-Hemmer

SPC Number:

Dates

Filing date:

17/09/2002

Grant date:

08/02/2012

EP Publication Date:

08/02/2012

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

30/09/2009

EP B1 Publication Date:

08/02/2012

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

17/09/2012

Expiration date:

17/09/2022

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

17/09/2002

 

 

Name:

Bristol-Myers Squibb Company

Address:

Route 206 and Province Line Road, Princeton, NJ 08543-4000, United States (US)

Inventor

1

Name:

Quan Mimi

Address:

United States (US)

2

Name:

Orwat Michael

Address:

United States (US)

3

Name:

Qiao Jennifer X

Address:

United States (US)

4

Name:

Han Wei

Address:

United States (US)

5

Name:

Koch Stephanie

Address:

United States (US)

6

Name:

Pinto Donald

Address:

United States (US)

7

Name:

Lam Patrick

Address:

United States (US)

8

Name:

Li Yun-Long

Address:

United States (US)

Priority

Priority Number:

324165 P

Priority Date:

21/09/2001

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 213/75;

Filing date	Document type	Number of pages